Mayne Pharma Group (MYX.AX)

Earnings in 2026: NZ$44.24 Million

According to Mayne Pharma Group's latest financial reports the company's current earnings are NZ$0.26 Billion. In 2026 the company made an earning of NZ$44.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Mayne Pharma Group from 2007 to 2026

Annual earnings

Year	Earnings	Change
2026	NZ$44.24 M
2024	-NZ$0.23 Billion	-29.42%
2023	-NZ$0.33 Billion	19.63%
2022	-NZ$0.27 Billion	-24.06%
2021	-NZ$0.36 Billion	111.77%
2020	-NZ$0.17 Billion	-62.39%
2019	-NZ$0.45 Billion	101.2%
2018	-NZ$0.23 Billion	-238.72%
2017	NZ$0.15 B	139.78%
2016	NZ$66.44 M	329.14%
2015	NZ$15.48 M	-67.26%
2014	NZ$47.29 M	-4217.24%
2013	-NZ$1.15 Million	-108.08%
2012	NZ$14.21 M	-592.49%
2011	-NZ$2.89 Million	-414.65%
2010	NZ$0.91 M	-115.35%
2009	-NZ$5.98 Million	0.47%
2008	-NZ$5.95 Million	115.05%
2007	-NZ$2.77 Million

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Earnings for Mayne Pharma Group (MYX.AX)